As with many other IEIs, allogeneic hematopoietic cell transplantation (HCT) was initially performed as a curative treatment for patients with STAT3-GOF; however, transplantation complications such as infections and graft-versus-host disease often led to patient death or critical adverse events [9, 17]. This evidence concerns the gene STAT3 and graft versus host disease.